Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Attention-Deficit/Hyperactivity Disorder01:30

Attention-Deficit/Hyperactivity Disorder

602
Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder characterized by persistent inattention, hyperactivity, and impulsivity. It affects approximately 5-8% of children globally, with around 60-70% of cases persisting into adulthood. ADHD has significant implications for educational attainment, social interactions, and occupational success.
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings....
602
Psychosis: Goals of Pharmacotherapy01:26

Psychosis: Goals of Pharmacotherapy

356
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
356
Drug Therapy01:28

Drug Therapy

185
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
185
Modeling in Therapy01:26

Modeling in Therapy

286
Modeling, a key technique in therapy, uses observational learning to help clients acquire and practice new skills by watching therapists demonstrate desired behaviors. This approach, rooted in Albert Bandura's concept of vicarious learning, plays a significant role in therapeutic interventions for various psychological conditions, including social anxiety, ADHD, and depression.
Participant Modeling
Participant modeling involves therapists demonstrating calm and effective behaviors in...
286
Operant Conditioning Intervention01:24

Operant Conditioning Intervention

341
Operant conditioning serves as a foundational principle in therapeutic interventions aimed at modifying maladaptive behaviors. Central to this approach is the notion that behaviors, both adaptive and maladaptive, are learned through reinforcement. By analyzing the environmental factors that reinforce problematic behaviors, clinicians can design interventions to weaken these reinforcements and replace maladaptive behaviors with healthier alternatives.
In operant conditioning, behaviors that are...
341
Psychosis and Antipsychotic Drugs: Overview01:28

Psychosis and Antipsychotic Drugs: Overview

670
The term "psychosis" refers to a spectrum of mental disorders characterized by abnormal thoughts, perceptions, and behaviors. It can manifest as mood disorders, dementia, delirium with psychotic features, substance-induced psychosis with psychotic features, brief psychotic disorder, delusional disorder, schizoaffective disorder, and schizophrenia. Among all these disorders, schizophrenia is the most common psychotic disorder, affecting 1% of the worldwide population. Psychotic...
670

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Advancing past ketamine: emerging glutamatergic compounds for the treatment of depression.

European archives of psychiatry and clinical neuroscience·2024
Same author

Corrigendum to "Efficacy of a synbiotic in the management of adults with Attention-Deficit and Hyperactivity Disorder and/or Borderline Personality Disorder and high levels of irritability: Results from a multicenter, randomized, placebo-controlled, "basket" trial" [Brain Behav. Immun. 120 (2024) 360-371].

Brain, behavior, and immunity·2024
Same author

Synaptic proteome perturbations after maternal immune activation: Identification of embryonic and adult hippocampal changes.

Brain, behavior, and immunity·2024
Same author

Assessing the Accuracy of Smartwatch-Based Estimation of Maximum Oxygen Uptake Using the Apple Watch Series 7: Validation Study.

JMIR biomedical engineering·2024
Same author

Exploring weight-related self-monitoring as a potential risk factor for eating disorder symptoms in adults - A systematic review and meta-analysis.

Appetite·2024
Same author

Genome-wide association study of major anxiety disorders in 122,341 European-ancestry cases identifies 58 loci and highlights GABAergic signaling.

medRxiv : the preprint server for health sciences·2024

Related Experiment Video

Updated: Dec 9, 2025

The Adventures of Fundi Intervention Based on the Cognitive and Emotional Processing in Attention Deficit Hyperactive Disorder Patients
05:48

The Adventures of Fundi Intervention Based on the Cognitive and Emotional Processing in Attention Deficit Hyperactive Disorder Patients

Published on: June 12, 2020

6.2K

[Transition psychiatry: attention deficit/hyperactivity disorder].

Tobias Banaschewski1, Christa Roth-Sackenheim2, Gundolf Berg3

  • 1Zentralinstitut für Seelische Gesundheit, Medizinische Fakultät Mannheim Universität Heidelberg, Mannheim.

Zeitschrift Fur Kinder- Und Jugendpsychiatrie Und Psychotherapie
|September 7, 2020
PubMed
Summary

Attention deficit/hyperactivity disorder (ADHD) is a common neurodevelopmental disorder affecting children and adults. Many adults with ADHD risk treatment discontinuation during the transition to adulthood, requiring optimized care strategies.

Keywords:
ADHDADHSAdoleszenzBehandlungTransitionspsychiatrieVersorgungssystemeadolescenceservice systemstransition medicinetreatment

More Related Videos

Event Related Potentials ERPs and other EEG Based Methods for Extracting Biomarkers of Brain Dysfunction: Examples from Pediatric Attention Deficit/Hyperactivity Disorder ADHD
10:02

Event Related Potentials ERPs and other EEG Based Methods for Extracting Biomarkers of Brain Dysfunction: Examples from Pediatric Attention Deficit/Hyperactivity Disorder ADHD

Published on: March 12, 2020

16.4K
Using Brain Activation nir-HEG/Q-EEG and Execution Measures CPTs in a ADHD Assessment Protocol
13:09

Using Brain Activation nir-HEG/Q-EEG and Execution Measures CPTs in a ADHD Assessment Protocol

Published on: April 1, 2018

10.7K

Related Experiment Videos

Last Updated: Dec 9, 2025

The Adventures of Fundi Intervention Based on the Cognitive and Emotional Processing in Attention Deficit Hyperactive Disorder Patients
05:48

The Adventures of Fundi Intervention Based on the Cognitive and Emotional Processing in Attention Deficit Hyperactive Disorder Patients

Published on: June 12, 2020

6.2K
Event Related Potentials ERPs and other EEG Based Methods for Extracting Biomarkers of Brain Dysfunction: Examples from Pediatric Attention Deficit/Hyperactivity Disorder ADHD
10:02

Event Related Potentials ERPs and other EEG Based Methods for Extracting Biomarkers of Brain Dysfunction: Examples from Pediatric Attention Deficit/Hyperactivity Disorder ADHD

Published on: March 12, 2020

16.4K
Using Brain Activation nir-HEG/Q-EEG and Execution Measures CPTs in a ADHD Assessment Protocol
13:09

Using Brain Activation nir-HEG/Q-EEG and Execution Measures CPTs in a ADHD Assessment Protocol

Published on: April 1, 2018

10.7K

Area of Science:

  • Psychiatry
  • Neurodevelopmental Disorders
  • Pediatrics

Background:

  • Attention deficit/hyperactivity disorder (ADHD) is a prevalent neurodevelopmental disorder impacting 5% of children and adolescents and 2-3% of adults.
  • ADHD frequently co-occurs with other disorders and leads to significant functional impairments.
  • Administrative data reveal a high risk of treatment discontinuation for ADHD patients transitioning into adulthood, despite ongoing symptoms and functional deficits.

Purpose of the Study:

  • To examine the challenges and consequences of treatment discontinuation in adults with ADHD during the critical transition period.
  • To identify strategies for optimizing ADHD treatment and care management for young adults.

Main Methods:

  • Review of administrative data concerning ADHD patient treatment patterns.
  • Analysis of factors contributing to treatment discontinuation in the transition to adulthood.
  • Exploration of potential interventions for sustained ADHD management.

Main Results:

  • A significant proportion of adult ADHD patients face treatment discontinuation.
  • Persistent symptomatology and functional impairments are common in this population.
  • The transition to adulthood presents unique challenges for maintaining consistent ADHD care.

Conclusions:

  • Optimizing ADHD treatment during the transition to adulthood is crucial for long-term patient outcomes.
  • Proactive strategies are needed to mitigate treatment discontinuation and ensure continuity of care.
  • Further research into tailored interventions for young adults with ADHD is warranted.